Obligation Philip Morris Global 1.875% ( US718172BF50 ) en USD

Philip Morris Global

100 % ▲

Etas-Unis

US718172BF50 ( en USD )

1.875% par an ( paiement semestriel )

15/01/2019 - Obligation échue

Prospectus brochure de l'obligation Philip Morris International US718172BF50 en USD 1.875%, échue

2 000 USD

750 000 000 USD

718172BF5

N/A

Philip Morris International est une entreprise multinationale de tabac produisant et vendant des cigarettes et des produits de tabac chauffé dans le monde entier, à l'exception des États-Unis.

L'Obligation émise par Philip Morris Global ( Etas-Unis ) , en USD, avec le code ISIN US718172BF50, paye un coupon de 1.875% par an.
Le paiement des coupons est semestriel et la maturité de l'Obligation est le 15/01/2019

FINAL PROSPECTUS SUPPLEMENT
http://www.sec.gov/Archives/edgar/data/1413329/000119312513429585...
424B2 1 d619778d424b2.htm FINAL PROSPECTUS SUPPLEMENT
Table of Contents
Filed Pursuant to Rule 424(b)(2)
Registration No. 333-172490
CALCULATION OF REGISTRATION FEE

Maximum
Maximum
Amount of
Title of Each Class of
Amount to be
Offering Price
Aggregate
Registration
Securities to be Registered

Registered

Per Unit

Offering Price

Fee(1)(2)
1.875% Notes due January 15, 2019

$750,000,000
99.221%

$744,157,500
$95,847.49
3.600% Notes due November 15, 2023

$500,000,000
99.277%

$496,385,000
$63,934.39
4.875% Notes due November 15, 2043

$750,000,000
99.422%

$745,665,000
$96,041.65

(1) Calculated in accordance with Rule 457(r) under the Securities Act of 1933, as amended. The total registration fee due for this
offering is $255,823.53.
(2) Paid herewith.
1 of 53
11/6/2013 1:55 PM

FINAL PROSPECTUS SUPPLEMENT
http://www.sec.gov/Archives/edgar/data/1413329/000119312513429585...
Table of Contents
Prospectus Supplement to Prospectus dated February 28, 2011

$750,000,000 1.875% Notes due 2019
$500,000,000 3.600% Notes due 2023
$750,000,000 4.875% Notes due 2043

The notes due 2019 will mature on January 15, 2019, the notes due 2023 will mature on November 15, 2023 and the notes due
2043 will mature on November 15, 2043. Interest on the notes due 2019 is payable semiannually on January 15 and July 15 of each
year, beginning July 15, 2014. Interest on the notes due 2023 is payable semiannually on May 15 and November 15 of each year,
beginning May 15, 2014. Interest on the notes due 2043 is payable semiannually on May 15 and November 15 of each year, beginning
May 15, 2014. We may not redeem the notes prior to maturity unless specified events occur involving United States taxation. The
notes will be our senior unsecured obligations and will rank equally in right of payment with all of our other senior unsecured
indebtedness from time to time outstanding. The notes will be issued only in denominations of $2,000 and integral multiples of $1,000
in excess thereof.
Application will be made to have the notes listed on the New York Stock Exchange.
See "Risk Factors" on page S-5 of this prospectus supplement.
Neither the Securities and Exchange Commission nor any other regulatory body has approved or disapproved of these
securities or determined if this prospectus supplement or the attached prospectus is truthful or complete. Any representation
to the contrary is a criminal offense.

Public
Underwriting
Proceeds to Us

Offering Price

Discount

(before expenses)

Per
Per
Per

Note

Total

Note

Total

Note

Total

1.875% Notes due 2019
99.221% $744,157,500 0.300% $2,250,000 98.921% $741,907,500
3.600% Notes due 2023
99.277% $496,385,000 0.450% $2,250,000 98.827% $494,135,000
4.875% Notes due 2043
99.422% $745,665,000 0.750% $5,625,000 98.672% $740,040,000
The public offering prices set forth above do not include accrued interest. Interest on the notes of each series will accrue from
November 12, 2013.

The underwriters expect to deliver the notes of each series to purchasers in book-entry form only through The Depository Trust
Company, or DTC, Clearstream Banking, société anonyme, or Clearstream, or Euroclear Bank S.A./N.V., or Euroclear, on or about
November 12, 2013.
Joint Book-Running Managers

Barclays

Citigroup

Credit Suisse

HSBC

J.P. Morgan
Co-Managers

Banca IMI

BBVA

ING
Santander
UBS Investment Bank
2 of 53
11/6/2013 1:55 PM

FINAL PROSPECTUS SUPPLEMENT
http://www.sec.gov/Archives/edgar/data/1413329/000119312513429585...
Prospectus Supplement dated November 4, 2013
3 of 53
11/6/2013 1:55 PM

FINAL PROSPECTUS SUPPLEMENT
http://www.sec.gov/Archives/edgar/data/1413329/000119312513429585...
Table of Contents
TABLE OF CONTENTS

PROSPECTUS SUPPLEMENT

PROSPECTUS

ABOUT THIS PROSPECTUS SUPPLEMENT

S-1 ABOUT THIS PROSPECTUS

i

FORWARD-LOOKING AND CAUTIONARY
WHERE YOU CAN FIND MORE INFORMATION

i

STATEMENTS

S-2 DOCUMENTS INCORPORATED BY REFERENCE

ii
SUMMARY OF THE OFFERING

S-3 FORWARD-LOOKING AND CAUTIONARY
RISK FACTORS

S-5
STATEMENTS

iii
THE COMPANY

S-6 THE COMPANY

1
USE OF PROCEEDS

S-7 RISK FACTORS

2
RATIOS OF EARNINGS TO FIXED CHARGES

S-7 USE OF PROCEEDS

2
SUMMARY OF SELECTED HISTORICAL
RATIOS OF EARNINGS TO FIXED CHARGES

2
FINANCIAL DATA

S-8 DESCRIPTION OF DEBT SECURITIES

3
DESCRIPTION OF NOTES

S-9 DESCRIPTION OF DEBT WARRANTS

15
CERTAIN U.S. FEDERAL INCOME TAX
PLAN OF DISTRIBUTION

17
CONSIDERATIONS

S-16
LEGAL MATTERS

17
UNDERWRITING

S-21
EXPERTS

17
OFFERING RESTRICTIONS

S-23
DOCUMENTS INCORPORATED BY REFERENCE S-25
LEGAL MATTERS

S-25
EXPERTS

S-25

We have not, and the underwriters have not, authorized anyone to provide you with any information other than that
contained or incorporated by reference in this prospectus supplement, any related free writing prospectus and the attached
prospectus. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that
others may give you. If the information varies between this prospectus supplement and the attached prospectus, the
information in this prospectus supplement supersedes the information in the attached prospectus. We are not making an offer
of these securities in any jurisdiction where the offer or sale is not permitted. Neither the delivery of this prospectus
supplement, any related free writing prospectus or the attached prospectus, nor any sale made hereunder and thereunder,
shall under any circumstances create any implication that there has been no change in our affairs since the date of this
prospectus supplement, any related free writing prospectus or the attached prospectus, regardless of the time of delivery of
such document or any sale of securities offered hereby or thereby, or that the information contained or incorporated by
reference herein or therein is correct as of any time subsequent to the date of such information.

In connection with the issuance of the notes, Barclays Capital Inc., Citigroup Global Markets Inc., Credit Suisse
Securities (USA) LLC, HSBC Securities (USA) Inc. and J.P. Morgan Securities LLC or their respective affiliates may
over-allot or effect transactions that stabilize or maintain the market price of the notes at levels higher than that which might
otherwise prevail. In any jurisdiction where there can only be one stabilizing agent, Citigroup Global Markets Inc. or its
affiliates shall effect such transactions. This stabilizing, if commenced, may be discontinued at any time and will be carried out
in compliance with applicable laws, regulations and rules.

i
4 of 53
11/6/2013 1:55 PM

FINAL PROSPECTUS SUPPLEMENT
http://www.sec.gov/Archives/edgar/data/1413329/000119312513429585...
Table of Contents
The distribution of this prospectus supplement and the attached prospectus and the offering or sale of the notes in some
jurisdictions may be restricted by law. The notes are offered globally for sale in those jurisdictions in the United States, Europe, Asia
and elsewhere where it is lawful to make such offers. Persons into whose possession this prospectus supplement and the attached
prospectus come are required by us and the underwriters to inform themselves about, and to observe, any applicable restrictions. This
prospectus supplement and the attached prospectus may not be used for or in connection with an offer or solicitation by any person in
any jurisdiction in which that offer or solicitation is not authorized or to any person to whom it is unlawful to make that offer or
solicitation. See "Offering Restrictions" in this prospectus supplement.
Notice to Prospective Investors in the European Economic Area
This prospectus supplement and the attached prospectus have been prepared on the basis that any offer of notes in any Member
State of the European Economic Area (the "EEA") that has implemented the Prospectus Directive (2003/71/EC) (each, a "Relevant
Member State") will be made pursuant to an exemption under the Prospectus Directive, as implemented in that Relevant Member
State, from the requirement to produce a prospectus for offers of notes. Accordingly, any person making or intending to make any offer
in that Relevant Member State of notes which are the subject of the offering contemplated by this prospectus supplement and the
attached prospectus may only do so in circumstances in which no obligation arises for us or any of the underwriters to produce a
prospectus pursuant to Article 3 of the Prospectus Directive in relation to such offer. Neither we nor the underwriters have
authorized, nor do we or they authorize, the making of any offer of notes in circumstances in which an obligation arises for us or the
underwriters to publish a prospectus for such offer.
Notice to Prospective Investors in the United Kingdom
This prospectus supplement and attached prospectus are only being distributed to, and are only directed at, persons in the United
Kingdom that are qualified investors within the meaning of Article 2(1)(e) of the Prospectus Directive and that are also
(1) investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion)
Order 2005 (the "Order") or (2) high net worth entities, and other persons to whom it may lawfully be communicated, falling within
Article 49(2)(a) to (d) of the Order (each such person being referred to as a "Relevant Person"). This prospectus supplement and
attached prospectus and their contents are confidential and should not be distributed, published or reproduced (in whole or in part) or
disclosed by recipients to any other persons in the United Kingdom. Any person in the United Kingdom that is not a Relevant Person
should not act or rely on this prospectus supplement and/or attached prospectus or any of their contents.
This prospectus supplement and attached prospectus have not been approved for the purposes of Section 21 of the UK Financial
Services and Markets Act 2000 ("FSMA") by a person authorized under FSMA. This prospectus supplement and the attached
prospectus are being distributed and communicated to persons in the United Kingdom only in circumstances in which Section 21(1) of
FSMA does not apply.
The notes are not being offered or sold to any person in the United Kingdom except in circumstances which will not result in an
offer of securities to the public in the United Kingdom within the meaning of Part VI of FSMA.

ii
5 of 53
11/6/2013 1:55 PM

FINAL PROSPECTUS SUPPLEMENT
http://www.sec.gov/Archives/edgar/data/1413329/000119312513429585...
Table of Contents
ABOUT THIS PROSPECTUS SUPPLEMENT
This prospectus supplement contains the terms of this offering of notes. This prospectus supplement, or the information
incorporated by reference in this prospectus supplement, may add, update or change information in the attached prospectus. If
information in this prospectus supplement or the information that is incorporated by reference in this prospectus supplement is
inconsistent with the attached prospectus, this prospectus supplement, or the information incorporated by reference in this prospectus
supplement, will apply and will supersede that information in the attached prospectus.
It is important for you to read and consider all information contained in this prospectus supplement, the attached prospectus and
any related free writing prospectus in making your investment decision. You should also read and consider the information in the
documents we have referred you to in "Documents Incorporated by Reference" in this prospectus supplement and "Where You Can
Find More Information" in the attached prospectus, including our Annual Report on Form 10-K for the year ended December 31, 2012
and the portions of our Definitive Proxy Statement on Schedule 14A filed with the SEC on March 28, 2013 that are incorporated by
reference therein, our Quarterly Reports on Form 10-Q for the quarters ended March 31, 2013, June 30, 2013 and September 30,
2013, our Current Reports on Form 8-K filed with the SEC on February 7, 2013 (the Item 8.01 Form 8-K only), February 12,
2013, February 15, 2013, February 20, 2013, March 4, 2013, March 13, 2013, March 19, 2013, May 8, 2013, May 14, 2013, May 21,
2013 and June 3, 2013 and our Current Report on Form 8-K/A filed with the SEC on June 13, 2013.
Application will be made to have the notes listed on the New York Stock Exchange. We cannot guarantee that listing will be
obtained.
Trademarks and servicemarks in this prospectus supplement and the attached prospectus appear in bold italic type and are the
property of or licensed by our subsidiaries.
Philip Morris International Inc. is a Virginia holding company incorporated in 1987. Unless otherwise indicated, all references
in this prospectus supplement to "PMI," "us," "our," or "we" refer to Philip Morris International Inc. and its subsidiaries.
References herein to "$," "dollars" and "U.S. dollars" are to United States dollars, and all financial data included or
incorporated by reference herein have been presented in accordance with accounting principles generally accepted in the United
States of America.

S-1
6 of 53
11/6/2013 1:55 PM

FINAL PROSPECTUS SUPPLEMENT
http://www.sec.gov/Archives/edgar/data/1413329/000119312513429585...
Table of Contents
FORWARD-LOOKING AND CAUTIONARY STATEMENTS
We may from time to time make forward-looking statements, including in information included or incorporated by reference in
this prospectus supplement and the attached prospectus. You can identify these forward-looking statements by use of words such as
"strategy," "expects," "continues," "plans," "anticipates," "believes," "will," "estimates," "intends," "projects," "goals," "targets"
and other words of similar meaning. You can also identify them by the fact that they do not relate strictly to historical or current facts.
We cannot guarantee that any forward-looking statement will be realized, although we believe we have been prudent in our
plans and assumptions. Achievement of future results is subject to risks, uncertainties and inaccurate assumptions. Should known or
unknown risks or uncertainties materialize, or should underlying assumptions prove inaccurate, actual results could vary materially
from those anticipated, estimated or projected. You should bear this in mind as you consider forward-looking statements and whether
to invest in or remain invested in our securities. In connection with the "safe harbor" provisions of the Private Securities Litigation
Reform Act of 1995, we have identified important factors in the documents incorporated by reference that, individually or in the
aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking statements made
by us; any such statement is qualified by reference to these cautionary statements. We elaborate on these and other risks we face in the
documents incorporated by reference. You should understand that it is not possible to predict or identify all risk factors.
Consequently, you should not consider risks discussed in the documents incorporated by reference to be a complete discussion of all
potential risks or uncertainties. We do not undertake to update any forward-looking statement that we may make from time to time
except in the normal course of our public disclosure obligations.

S-2
7 of 53
11/6/2013 1:55 PM

FINAL PROSPECTUS SUPPLEMENT
http://www.sec.gov/Archives/edgar/data/1413329/000119312513429585...
Table of Contents
SUMMARY OF THE OFFERING
The following summary contains basic information about the notes and is not intended to be complete. It does not contain all
the information that is important to you. For a more detailed description of the notes, please refer to the section entitled
"Description of Notes" in this prospectus supplement and the section entitled "Description of Debt Securities" in the attached
prospectus.

Issuer
Philip Morris International Inc.

Securities Offered
$750,000,000 total principal amount of 1.875% notes due 2019, maturing
January 15, 2019.

$500,000,000 total principal amount of 3.600% notes due 2023, maturing

November 15, 2023.

$750,000,000 total principal amount of 4.875% notes due 2043, maturing

November 15, 2043.

Interest Rates
The notes due 2019 will bear interest from November 12, 2013 at the rate of
1.875% per annum.

The notes due 2023 will bear interest from November 12, 2013 at the rate of

3.600% per annum.

The notes due 2043 will bear interest from November 12, 2013 at the rate of

4.875% per annum.

Interest Payment Dates
For the notes due 2019, January 15 and July 15, of each year, beginning on July
15, 2014.

For the notes due 2023, May 15 and November 15, of each year, beginning on

May 15, 2014.

For the notes due 2043, May 15 and November 15, of each year, beginning on

May 15, 2014.

Ranking
The notes will be our senior unsecured obligations and will rank equally in right
of payment with all of our existing and future senior unsecured indebtedness.
Because we are a holding company, the notes will effectively rank junior to any
indebtedness or other liabilities of our subsidiaries. The indenture does not limit
the amount of debt or other liabilities we or our subsidiaries may issue.

Optional Tax Redemption
We may redeem all, but not part, of the notes of each series upon the occurrence
of specified tax events described under the heading "Description of Notes--
Redemption for Tax Reasons" in this prospectus supplement.

Covenants
We will issue the notes under an indenture containing covenants that restrict our
ability, with significant exceptions, to:

· incur debt secured by liens; and

· engage in sale and leaseback transactions.

S-3
8 of 53
11/6/2013 1:55 PM

FINAL PROSPECTUS SUPPLEMENT
http://www.sec.gov/Archives/edgar/data/1413329/000119312513429585...
Table of Contents
Use of Proceeds
We will receive net proceeds (before expenses) from this offering of
approximately $1,976,082,500. We intend to add the net proceeds to our general
funds, which may be used:

· to meet our working capital requirements;

· to repurchase our common stock;

· to refinance debt; or

· for general corporate purposes.

If we do not use the net proceeds immediately, we will temporarily invest them

in short-term, interest-bearing obligations.

Listing
Application will be made to list the notes on the New York Stock Exchange.

Clearance and Settlement
The notes will be cleared through DTC, Clearstream and Euroclear.

Governing Law
The notes will be governed by the laws of the State of New York.

Risk Factors
Investing in the notes involves risks. See "Risk Factors" and the documents
incorporated or deemed to be incorporated by reference herein for a discussion
of the factors you should consider carefully before deciding to invest in the
notes.

Trustee
HSBC Bank USA, National Association.

S-4
9 of 53
11/6/2013 1:55 PM

FINAL PROSPECTUS SUPPLEMENT
http://www.sec.gov/Archives/edgar/data/1413329/000119312513429585...
Table of Contents
RISK FACTORS
You should carefully consider all the information included and incorporated by reference in this prospectus supplement and the
accompanying prospectus before deciding to invest in the notes. In particular, we urge you to consider carefully the factors set forth
under "Forward-Looking and Cautionary Statements" in this prospectus supplement and "Risk Factors" in our Annual Report on Form
10-K for the year ended December 31, 2012 and our Quarterly Reports on Form 10-Q for the quarters ended March 31,
2013, June 30, 2013 and September 30, 2013, which we have incorporated by reference in this prospectus supplement.

S-5
10 of 53
11/6/2013 1:55 PM